IBDEI0N3 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10992,1,2,0)
 ;;=2^V58.62
 ;;^UTILITY(U,$J,358.3,10992,1,5,0)
 ;;=5^L/T (Current) Antibiotics Use
 ;;^UTILITY(U,$J,358.3,10992,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,10993,0)
 ;;=V58.63^^47^611^26
 ;;^UTILITY(U,$J,358.3,10993,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10993,1,2,0)
 ;;=2^V58.63
 ;;^UTILITY(U,$J,358.3,10993,1,5,0)
 ;;=5^L/T (Current) Antiplts/Antithrmbtcs
 ;;^UTILITY(U,$J,358.3,10993,2)
 ;;=^329978
 ;;^UTILITY(U,$J,358.3,10994,0)
 ;;=V58.64^^47^611^30
 ;;^UTILITY(U,$J,358.3,10994,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10994,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,10994,1,5,0)
 ;;=5^L/T (Current) NSAIDS Use
 ;;^UTILITY(U,$J,358.3,10994,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,10995,0)
 ;;=V58.65^^47^611^32
 ;;^UTILITY(U,$J,358.3,10995,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10995,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,10995,1,5,0)
 ;;=5^L/T (Current) Steroids Use
 ;;^UTILITY(U,$J,358.3,10995,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,10996,0)
 ;;=V58.66^^47^611^27
 ;;^UTILITY(U,$J,358.3,10996,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10996,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,10996,1,5,0)
 ;;=5^L/T (Current) Aspirin Use
 ;;^UTILITY(U,$J,358.3,10996,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,10997,0)
 ;;=V58.67^^47^611^29
 ;;^UTILITY(U,$J,358.3,10997,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10997,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,10997,1,5,0)
 ;;=5^L/T (Current) Insulin Use
 ;;^UTILITY(U,$J,358.3,10997,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,10998,0)
 ;;=V58.68^^47^611^28
 ;;^UTILITY(U,$J,358.3,10998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10998,1,2,0)
 ;;=2^V58.68
 ;;^UTILITY(U,$J,358.3,10998,1,5,0)
 ;;=5^L/T (Current) Bisphos Use
 ;;^UTILITY(U,$J,358.3,10998,2)
 ;;=^340624
 ;;^UTILITY(U,$J,358.3,10999,0)
 ;;=V58.69^^47^611^31
 ;;^UTILITY(U,$J,358.3,10999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10999,1,2,0)
 ;;=2^V58.69
 ;;^UTILITY(U,$J,358.3,10999,1,5,0)
 ;;=5^L/T (Current) Other Meds Use
 ;;^UTILITY(U,$J,358.3,10999,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,11000,0)
 ;;=V58.83^^47^611^50
 ;;^UTILITY(U,$J,358.3,11000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11000,1,2,0)
 ;;=2^V58.83
 ;;^UTILITY(U,$J,358.3,11000,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,11000,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,11001,0)
 ;;=V62.5^^47^611^34
 ;;^UTILITY(U,$J,358.3,11001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11001,1,2,0)
 ;;=2^V62.5
 ;;^UTILITY(U,$J,358.3,11001,1,5,0)
 ;;=5^Legal Circumstances
 ;;^UTILITY(U,$J,358.3,11001,2)
 ;;=^175799
 ;;^UTILITY(U,$J,358.3,11002,0)
 ;;=V79.1^^47^612^1
 ;;^UTILITY(U,$J,358.3,11002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11002,1,2,0)
 ;;=2^V79.1
 ;;^UTILITY(U,$J,358.3,11002,1,5,0)
 ;;=5^Alcohol Screen
 ;;^UTILITY(U,$J,358.3,11002,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,11003,0)
 ;;=V61.21^^47^612^8
 ;;^UTILITY(U,$J,358.3,11003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11003,1,2,0)
 ;;=2^V61.21
 ;;^UTILITY(U,$J,358.3,11003,1,5,0)
 ;;=5^Victim Child Abuse Counseling
 ;;^UTILITY(U,$J,358.3,11003,2)
 ;;=^304301
 ;;^UTILITY(U,$J,358.3,11004,0)
 ;;=V65.40^^47^612^2
 ;;^UTILITY(U,$J,358.3,11004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11004,1,2,0)
 ;;=2^V65.40
 ;;^UTILITY(U,$J,358.3,11004,1,5,0)
 ;;=5^Counseling NOS
 ;;^UTILITY(U,$J,358.3,11004,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,11005,0)
 ;;=V65.42^^47^612^7
 ;;^UTILITY(U,$J,358.3,11005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11005,1,2,0)
 ;;=2^V65.42
 ;;^UTILITY(U,$J,358.3,11005,1,5,0)
 ;;=5^Substance Use/Abuse Counseling
 ;;
 ;;$END ROU IBDEI0N3
